Close Menu
iM.NewsiM.News

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    David Sims Exhibition: From Kate Moss to Kurt Cobain

    November 18, 2026

    Brain Protein SORLA May Halt Alzheimer’s Tau Tangles

    November 18, 2026

    Nvidia RTX Spark Mini PCs Launch from Asus, Dell, and MSI

    November 18, 2026
    Facebook X (Twitter) Instagram
    iM.NewsiM.News
    Subscribe
    • Home
    • Lifestyle

      David Sims Exhibition: From Kate Moss to Kurt Cobain

      November 18, 2026

      Brain Protein SORLA May Halt Alzheimer’s Tau Tangles

      November 18, 2026

      Garvan Institute Finds NK Cell Defect in Rare Disease

      November 18, 2026

      U.S. Officially Loses Measles Elimination Status

      November 18, 2026

      Nicola Coughlan Reveals Shocking Comfort Food Mixes and Acting Struggles

      November 18, 2026
    • Relations

      UK-EU Reset Deal Draft Reveals Youth Mobility and Cheese Terms

      November 18, 2026

      Hakeem Jeffries Set to Become First Black House Speaker

      November 18, 2026

      Trump, Xi, and Putin Shake Hands at Historic China Summit

      November 18, 2026

      Xi Jinping welcomes Trump to Shenzhen for Apec summit

      November 18, 2026

      Rubio: Zero Evidence Linking Tech Outages to Cyberattacks

      November 18, 2026
    • Technology

      Nvidia RTX Spark Mini PCs Launch from Asus, Dell, and MSI

      November 18, 2026

      Shelly Neo Valve Stops Home Water Leaks in 12 Seconds

      November 18, 2026

      Artex AI Hacking Tool Targets Global Institutions

      November 18, 2026

      8BitDo GC Bluetooth Gamepad Brings GameCube Controller to Modern Consoles

      November 18, 2026

      PS5 Firmware Update Required for GTA VI Launch

      November 18, 2026
    • Travel & Tourism

      Climate Change Could Squeeze One Third of Tourist Destinations by 2050

      November 18, 2026

      Airlines Expand Routes as Indian Travel to Vietnam Surges

      November 18, 2026

      Air New Zealand Resumes Nonstop Flights From Christchurch to Tokyo and Perth

      November 18, 2026

      Why Anguilla Is the Caribbean’s Top Luxury Beach Destination

      November 17, 2026

      Dubai Airport Passenger Traffic Plunges 26% Amid Airline Exodus

      November 17, 2026
    • Get in Touch
    iM.NewsiM.News
    Home»Lifestyle»Health»HHS Allows Compounding Pharmacies to Make Popular Peptides
    Health

    HHS Allows Compounding Pharmacies to Make Popular Peptides

    im.newsBy im.newsOctober 29, 2026No Comments4 Mins Read13 Views
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    Pills and capsules on a pharmacy counter representing compounding peptides
    Photo: YipshaiukOWL / Wikimedia Commons, CC BY-SA 4.0
    Share
    Facebook Twitter LinkedIn Pinterest WhatsApp Email

    The Department of Health and Human Services (HHS) announced a new policy on Wednesday that will allow small compounding pharmacies to produce six popular peptides. This move effectively grants enforcement discretion, meaning federal regulators will not pursue legal action against these smaller facilities for making the substances without standard FDA approval.

    Health Secretary Robert F. Kennedy Jr. has publicly supported broader access to these compounds. He has stated that he uses some of the peptides himself and views them as beneficial for wellness. The policy aims to bring these substances out of the unregulated gray market and into a system with pharmacy standards and oversight.

    Shift from Gray Market to Compounding Pharmacies

    Peptides are short chains of amino acids that can have powerful effects on the body. While some occur naturally, many of the peptides currently in demand are synthetic. Wellness influencers and some clinicians have promoted them for various uses, despite a lack of rigorous scientific evidence regarding their safety and effectiveness.

    2023 Moździerz ceramiczny (1)
    Photo: Jacek Halicki / Wikimedia Commons, CC BY-SA 4.0

    Previously, these peptides were largely available through illicit online channels labeled for “research use only.” These products often came from overseas suppliers with questionable quality control. The new policy identifies compounding as a safer alternative to these unregulated sources.

    The enforcement discretion applies specifically to 503A compounding pharmacies. These are smaller facilities that typically prepare customized medications for individual patients. The policy does not extend to 503B outsourcing facilities, which are larger operations that produce higher volumes of medicines.

    Supply Constraints and Industry Reaction

    Pharmacy leaders have welcomed the decision as a step toward accountability. Scott Brunner, CEO of the Alliance for Pharmacy Compounding, stated that the policy offers a “more accountable alternative” for patients. He noted that it brings patients into a system where serious adverse event reporting and regulatory oversight apply.

    However, industry experts warn that supply will be limited. Joshua Fritzler, president of Olympia and Wesley Pharmaceuticals in Florida, said his company will likely only compound one of the six peptides initially. He explained that his smaller facility needs time to prepare and that the company will not be able to meet the high demand.

    Mortar and pestle laboratory1
    Photo: Unknown / Wikimedia Commons, Public domain

    Fritzler estimated that even all 503A pharmacies in the United States combined might struggle to satisfy patient needs. The delay is partly due to ingredient suppliers needing to ensure their active ingredients meet the new policy requirements. Pharmacies must also verify these ingredients before dispensing them.

    Safety Concerns and Regulatory Pushback

    Consumer advocacy groups have strongly criticized the move. Public Citizen, a nonprofit organization, argued that Kennedy acted unilaterally rather than through the standard rulemaking process. Dr. Robert Steinbrook, director of the Health Research Group at Public Citizen, stated that the decision undermines the FDA and threatens public health.

    Steinbrook advised clinicians to warn patients about the risks of contamination and other adverse effects. He emphasized that all peptide substances should undergo the standard FDA approval process for new drugs.

    Amber glass apothecary jars with labels on a shelf, Museu do Vidro, Marinha Grande, Portugal julesvernex2
    Photo: Jules Verne Times Two / Wikimedia Commons, CC BY-SA 4.0

    The Partnership for Safe Medicines, which includes various pharmacy organizations, filed a petition urging the FDA to ignore its own advisory committee’s July recommendation to allow compounding. The group pointed out that FDA scientists had previously recommended against unwinding restrictions due to concerns about the evidence supporting these substances.

    The policy does not change the legal status of the peptides themselves. It simply creates a path for small compounders to produce them without fear of federal enforcement. This leaves Americans in a regulatory gray area regarding the safety of these widely promoted wellness products.

    Source: NPR

    compounding FDA Health health policy pharmaceuticals wellness
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleGoogle Unveils Gemini 4 Carbon for Cybersecurity Tasks
    Next Article British Heritage Fashion Takes Over London Runways
    im.news

    Related Posts

    David Sims Exhibition: From Kate Moss to Kurt Cobain

    November 18, 2026

    Brain Protein SORLA May Halt Alzheimer’s Tau Tangles

    November 18, 2026

    Nvidia RTX Spark Mini PCs Launch from Asus, Dell, and MSI

    November 18, 2026
    Leave A Reply Cancel Reply

    Latest Posts

    David Sims Exhibition: From Kate Moss to Kurt Cobain

    November 18, 20261 Views

    Brain Protein SORLA May Halt Alzheimer’s Tau Tangles

    November 18, 20261 Views

    Nvidia RTX Spark Mini PCs Launch from Asus, Dell, and MSI

    November 18, 20260 Views

    Darren Aronofsky to Produce ‘Chip War’ Documentary

    November 18, 20260 Views
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    Don't Miss

    Epstein List Phase 1: Full Flight Logs, Client List Released

    February 28, 2025 News Focus 247 Views

    In a stunning development that has sent shockwaves through political and entertainment circles, Attorney General…

    Microsoft Stock Joins Exclusive $4 Trillion Club After Blockbuster Cloud + AI Earnings

    July 31, 2025

    DOJ & FBI Find No Epstein Client List, Suicide Confirmed

    July 7, 2025

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    About Us
    About Us

    We provide the daily life news. You find latest trendy news at our portal, from entertainment to economy or politics.

    We're accepting new partnerships right now.

    Email Us: info@im.news

    Facebook X (Twitter) RSS
    Our Picks

    David Sims Exhibition: From Kate Moss to Kurt Cobain

    November 18, 2026

    Brain Protein SORLA May Halt Alzheimer’s Tau Tangles

    November 18, 2026

    Nvidia RTX Spark Mini PCs Launch from Asus, Dell, and MSI

    November 18, 2026
    Most Popular

    Epstein List Phase 1: Full Flight Logs, Client List Released

    February 28, 2025247 Views

    Microsoft Stock Joins Exclusive $4 Trillion Club After Blockbuster Cloud + AI Earnings

    July 31, 2025208 Views

    DOJ & FBI Find No Epstein Client List, Suicide Confirmed

    July 7, 2025165 Views
    © 2026 I'm News. Designed by I'm News.
    • Home
    • Lifestyle
    • Relations
    • Travel & Tourism
    • Technology

    Type above and press Enter to search. Press Esc to cancel.